Atherosclerosis in apoE knockout mice infected with multiple pathogens

Journal of Infectious Diseases

Volumn 183, Issue 2, 2001, Pages 226-231

  Burnett, Mary Susan ^a   Gaydos, Charlotte A ^b   Madico, Guillermo E ^b   Glad, Stephanie M ^a   Paigen, Beverly ^d   Quinn, Thomas C ^b,c   Epstein, Stephen E ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE COURSE; KNOCKOUT MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS INFECTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; POLYMERASE CHAIN REACTION;

EID: 0035863436     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317938     Document Type: Article

References (55)

1. Cytomegalovirus and atherosclerosis
2. Cytomegalovirus antigen within human arterial smooth muscle cells
3. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis
4. Herpesviridae in the coronary arteries and aorta of young trauma victims
5. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection
6. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
7. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis
8. Cytomegalovirus/herpesvirus and carotid atherosclerosis: The ARIC study
9. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis
10. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis
11. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53
12. The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo
13. Human cytomegalovirus increases modified low-density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells
14. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of sub-clinical atherosclerosis
15. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
16. Patients with diabetes mellitus and atherosclerosis a role for cytomegalovirus
17. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis
18. Infection and atherosclerosis: Emerging mechanistic paradigms
19. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall
20. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
21. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease
22. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
23. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
24. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
25. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
26. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
27. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain
28. Rabbit model for Chlamydia pneumoniae infection
29. Chlamydia pneumoniae infection induces inflammatory changes in aortas of rabbits
30. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
31. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
32. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
33. Cytomegalovirus infection increases development of atherosclerosis in apoE knockout mice
34. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
35. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
36. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
37. Touchdown enzyme time release-PCR for detection and identification of C. pneumoniae, C. trachomatis and C. psittaci using the 16S and 16S-23S spacer rRNA genes
38. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H
39. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice
40. Quantitative assessment of atherosclerotic lesions in mice
41. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney
42. Phylogenetic relationship of Chlamydia pneumoniae to Chlamydia psittiaci and Chlamydia trachomatis as determined by analysis of 16S ribosomal DNA sequences
43. "Touchdown" PCR to circumvent spurious priming during gene amplification
44. Formalinized Chlamydia trachomatis organisms as antigens in the micro-immunofluorescence test
45. IFN-γ potentiates atherosclerosis in apoE knock-out mice
46. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-γ
47. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts
48. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-γ knockout recipients
49. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: Role of IFN-γ
50. Requirement for natural killer cell-produced interferon-γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
51. Interferon-γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels
52. Role of interferon-γ in murine cytomegalovirus infection
53. Correlation of survival from MCMV infection with spleen cell responsiveness to concanavalin A
54. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells: Characteristic of the killer cell
55. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells